Literature DB >> 15147237

Molecular modelling of the nucleotide-binding domain of Wilson's disease protein: location of the ATP-binding site, domain dynamics and potential effects of the major disease mutations.

Roman G Efremov1, Yuri A Kosinsky, Dmitry E Nolde, Ruslan Tsivkovskii, Alexander S Arseniev, Svetlana Lutsenko.   

Abstract

WNDP (Wilson's disease protein) is a copper-transporting ATPase that plays an essential role in human physiology. Mutations in WNDP result in copper accumulation in tissues and cause a severe hepato-neurological disorder known as Wilson's disease. Several mutations were surmised to affect the nucleotide binding and hydrolysis by WNDP; however, how the nucleotides bind to normal and mutated WNDP remains unknown. To aid such studies, we performed the molecular modelling of the spatial structure and dynamics of the ATP-binding domain of WNDP and its interactions with ATP. The three-dimensional models of this domain in two conformations were built using the X-ray structures of the Ca2+-ATPase in the E1 and E2 states. To study the functional aspects of the models, they were subjected to long-term molecular dynamics simulations in an explicit solvent; similar calculations were performed for the ATP-binding domain of Ca2+-ATPase. In both cases, we found large-scale motions that lead to significant changes of distances between several functionally important residues. The ATP docking revealed two possible modes of ATP binding: via adenosine buried in the cleft near residues H1069, R1151 and D1164, and via phosphate moiety 'anchored' by H-bonds with residues in the vicinity of catalytic D1027. Furthermore, interaction of ATP with both sites occurs if they are spatially close to each other. This may be achieved after relative domain motions of the 'closure' type observed in molecular dynamics simulations. The results provide a framework for analysis of disease mutations and for future mutagenesis studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147237      PMCID: PMC1133942          DOI: 10.1042/BJ20040326

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

Review 1.  Wilson disease.

Authors:  Jonathan D Gitlin
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

2.  The role of the invariant His-1069 in folding and function of the Wilson's disease protein, the human copper-transporting ATPase ATP7B.

Authors:  Ruslan Tsivkovskii; Roman G Efremov; Svetlana Lutsenko
Journal:  J Biol Chem       Date:  2003-01-27       Impact factor: 5.157

3.  Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features.

Authors:  W Kabsch; C Sander
Journal:  Biopolymers       Date:  1983-12       Impact factor: 2.505

4.  The nucleotide-binding domain of the Zn2+-transporting P-type ATPase from Escherichia coli carries a glycine motif that may be involved in binding of ATP.

Authors:  Juha Okkeri; Liisa Laakkonen; Tuomas Haltia
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

5.  ATP-induced conformational changes of the nucleotide-binding domain of Na,K-ATPase.

Authors:  Mark Hilge; Gregg Siegal; Geerten W Vuister; Peter Güntert; Sergio M Gloor; Jan Pieter Abrahams
Journal:  Nat Struct Biol       Date:  2003-06

6.  The distinct functional properties of the nucleotide-binding domain of ATP7B, the human copper-transporting ATPase: analysis of the Wilson disease mutations E1064A, H1069Q, R1151H, and C1104F.

Authors:  Clinton T Morgan; Ruslan Tsivkovskii; Yuri A Kosinsky; Roman G Efremov; Svetlana Lutsenko
Journal:  J Biol Chem       Date:  2004-06-17       Impact factor: 5.157

Review 7.  Structural basis of ion pumping by Ca(2+)-ATPase of sarcoplasmic reticulum.

Authors:  Chikashi Toyoshima; Hiromi Nomura; Yuji Sugita
Journal:  FEBS Lett       Date:  2003-11-27       Impact factor: 4.124

8.  Substrate-induced conformational fit and headpiece closure in the Ca2+ATPase (SERCA).

Authors:  Hailun Ma; Giuseppe Inesi; Chikashi Toyoshima
Journal:  J Biol Chem       Date:  2003-05-15       Impact factor: 5.157

9.  Mutational analysis of the Menkes copper P-type ATPase (ATP7A).

Authors:  I Voskoboinik; J Mar; J Camakaris
Journal:  Biochem Biophys Res Commun       Date:  2003-02-07       Impact factor: 3.575

Review 10.  Diagnosis and phenotypic classification of Wilson disease.

Authors:  Peter Ferenci; Karel Caca; Georgios Loudianos; Georgina Mieli-Vergani; Stuart Tanner; Irmin Sternlieb; Michael Schilsky; Diane Cox; Frieder Berr
Journal:  Liver Int       Date:  2003-06       Impact factor: 5.828

View more
  5 in total

1.  Solution structure of the N-domain of Wilson disease protein: distinct nucleotide-binding environment and effects of disease mutations.

Authors:  Oleg Dmitriev; Ruslan Tsivkovskii; Frits Abildgaard; Clinton T Morgan; John L Markley; Svetlana Lutsenko
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

Review 2.  Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes.

Authors:  P de Bie; P Muller; C Wijmenga; L W J Klomp
Journal:  J Med Genet       Date:  2007-08-23       Impact factor: 6.318

3.  Nucleotide-dependent conformational changes in HisP: molecular dynamics simulations of an ABC transporter nucleotide-binding domain.

Authors:  Jeff D Campbell; Sundeep Singh Deol; Frances M Ashcroft; Ian D Kerr; Mark S P Sansom
Journal:  Biophys J       Date:  2004-09-17       Impact factor: 4.033

4.  The T1048I mutation in ATP7A gene causes an unusual Menkes disease presentation.

Authors:  Gregorio León-García; Alfredo Santana; Nicolás Villegas-Sepúlveda; Concepción Pérez-González; José M Henrríquez-Esquíroz; Carlota de León-García; Carlos Wong; Isabel Baeza
Journal:  BMC Pediatr       Date:  2012-09-19       Impact factor: 2.125

5.  Elucidation of the ATP7B N-domain Mg2+-ATP coordination site and its allosteric regulation.

Authors:  Claude Hercend; Cyril Bauvais; Guillaume Bollot; Nicolas Delacotte; Philippe Chappuis; France Woimant; Jean-Marie Launay; Philippe Manivet
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.